Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 100 (4), 735-40

Neonatal Thrombocytopenia: Incidence and Characterization of Maternal Antiplatelet Antibodies by MAIPA Assay


Neonatal Thrombocytopenia: Incidence and Characterization of Maternal Antiplatelet Antibodies by MAIPA Assay

P de Moerloose et al. Br J Haematol.


Neonatal thrombocytopenia (NNT) which is frequent in distressed newborns was uncommon in a non-selected population of neonates. The aim of this prospective study was to determine the frequency of NNT and, in confirmed NNT, to search for maternal antiplatelet antibodies with a monoclonal antibody-specific immobilization of platelet antigens (MAIPA) assay. Among the 8388 newborns studied, 40 (0.5%, 95% CI 0.3-0.6) had confirmed NNT, which was severe (platelet count < 50 x 10[9]/l) in 10 cases (0.12%, 95% CI 0.05-0.20). Antiplatelet antibodies were detected in 10/31 studied mothers of thrombocytopenic newborns (32.3%): they were alloantibodies in five cases and autoantibodies in five other cases. Among these 10 newborns, seven had severe thrombocytopenia and four had bleeding complications. As controls, antiplatelet antibodies were also searched for in mothers of non-thrombocytopenic newborns: antiplatelet antibodies were present in 8.5% (95% CI 5.9-11.7) of thrombocytopenic mothers (n = 400) and 3.2% (95% CI 0.7-9.0) of non-thrombocytopenic mothers (n = 95). The difference was significant between the control groups and the group of mothers of thrombocytopenic newborns. In conclusion, our data indicate that an immune origin is frequent in NNT and should be looked for, particularly when the platelet count is < 50 x 10(9)/l.

Similar articles

  • Maternal Antiplatelet Antibodies in Predicting Risk of Neonatal Thrombocytopenia
    F Boehlen et al. Obstet Gynecol 93 (2), 169-73. PMID 9932549.
    The monoclonal antibody-specific immobilization of platelet antigens assay did not predict the risk of neonatal thrombocytopenia in an unselected population of thrombocyt …
  • Neonatal and Maternal Thrombocytopenia: Incidence and Immune Background
    M Uhrynowska et al. Eur J Haematol 64 (1), 42-6. PMID 10680704.
    We performed a prospective study on the incidence of thrombocytopenia (t-penia) and its immunological origin in unselected 26,275 mothers and 24,101 newborns. Platelet an …
  • Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
    RF Burrows et al. N Engl J Med 329 (20), 1463-6. PMID 8413457.
    Moderate-to-severe fetal thrombocytopenia is a rare event. The only severely affected neonates with morbidity or mortality due to this condition are those born to mothers …
  • Diagnostics of Thrombocytopenias
    AV Mazurov et al. Ter Arkh 90 (7), 4-13. PMID 30701917. - Review
    Laboratory methods used for the diagnostics of thrombocytopenias are reviewed. Differential diagnosis is usually carried out between immune and hypoproductive forms of th …
  • [Immunologic Platelet Tests]
    JL Wautier. Transfus Clin Biol 7 Suppl 1, 69s-71s. PMID 10919228. - Review
    Platelet immunological assays have been used for several decades. The antiglobulin consummation test was the first to be introduced followed by the immunoradiometric tech …
See all similar articles

Cited by 2 PubMed Central articles

  • Neonatal Immune Thrombocytopenia
    U Raju et al. Med J Armed Forces India 60 (4), 333-6. PMID 27407670.
    Thus inspite of several therapeutic and preventive modalities being described, the optimum management strategy of immune mediated perinatal thrombocytopenia is yet in evo …
  • Neonatal Thrombocytopenia: Causes and Management
    I Roberts et al. Arch Dis Child Fetal Neonatal Ed 88 (5), F359-64. PMID 12937037. - Review
    Neonatal thrombocytopenia is a common clinical problem. Thrombocytopenia presenting in the first 72 hours of life is usually secondary to placental insufficiency and caus …

Publication types

LinkOut - more resources